vimarsana.com

Latest Breaking News On - Company recognition - Page 8 : vimarsana.com

Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update

Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update

Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

FORD MUSTANG MACH-E: FORD, KI JE POSTAVIL SVETOVNI REKORD V VARČNOSTI - Obvestila

FORD MUSTANG MACH-E Avtor: Summit Motors Ljubljana, d.o.o. Foto: Ford Priznanje je prevzel Tim Nicklin Z ultraučinkovito vožnjo od John O’Groatsa do Land’s Enda se je Fordov najnovejši povsem električni model Mustang Mach-E uvrstil v znamenito knjigo rekordov GUINNESS WORLD RECORD™. Neodvisno preverjeni podatki so pokazali, da je Ford Mustang Mach-E na kilovatno uro (kWh) električne energije prevozil več kot 10,4 kilometra in tako osvojil priznanje za najmanjšo porabo energije v električnem avtu. Z 88 kWh razpoložljive kapacitete baterije je dosežena učinkovitost potrdila znatno več kot 800 kilometrov dosega, kar za več kot 190 kilometrov presega uradni doseg Mustanga Mach-E, ki znaša 610 kilometrov, in obenem za trikrat presega cilj, ki so ga za ta novi rekord za električna vozila zastavili pri GUINNESS WORLD RECORDS™. Rekordni dosežek na najdaljšem britanskem potovanju je zahteval postanek za manj kot 45 minut polnjenja.

Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates

Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Read full article Oops! SARS-CoV-2 Variant Booster Program Update : Single booster dose of 50 µg of mRNA-1273 or mRNA-1273.351 increased neutralizing titers against SARS-CoV-2 and two Variants of Concern (B.1.351, P.1) in previously vaccinated clinical trial participants TeenCOVE Study Update : Initial analysis of the Phase 2/3 TeenCOVE study of mRNA-1273 showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date 2021 and 2022 Vaccine Manufacturing: Company increased its 2021 supply forecast to between 800 million and 1 billion doses; Company making investments to increase global supply for COVID-19 Vaccine to up to 3 billion doses in 2022

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.